Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
circFAM53B mRNA Vaccine + Toripalimab in Advanced Solid Tumors
NCT07245901Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
01
Overview
A Phase 2 trial of circFAM53B mRNA vaccine in solid tumor, sponsored by Sun Yat-sen Memorial Hospital. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
circFAM53B mRNA vaccine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07245901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245901.